Timing and treatment strategies according to SCAI classification in cardiogenic shock.

In patients with cardiogenic shock (CS), particularly those with acute myocardial infarction (AMI), evidence suggests that timely diagnosis and treatment interventions are critical in the prevention of haemo-metabolic compromise. Temporary mechanical circulatory support (tMCS) has shown potential in facilitating revascularization and recovery of patients with acute myocardial infarction cardiogenic shock (AMI-CS). Timing of treatment strategies for CS patients needs to be optimized for use of tMCS devices that are applicable to this heterogeneous patient population. Here, the latest evidence as well as the gaps in knowledge surrounding the role of time in the management of patients with CS is summarized.

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.

Déclaration de conflit d'intérêts

Conflict of interest Giuseppe Tarantini has received lecture fees from Edwards Lifesciences, Medtronic, Abbott, Boston Scientifics, Abiomed. Giulia Masiero has nothing to disclose. Alaide Chieffo has received lecture/consultant fees from Abbott, Abiomed, Biosensor, Boston Scientifics, Medtronic, Menarini, Shockwave Medical. Jacob Eifer Møller has received an institutional research grant from Abiomed and Novo Nordic Foundation and lecture honorary from Abbott, Abiomed, Boehringer Ingelheim, and Orion. Christian Hassager has received lecture honorarium from Abiomed and research grants from Novo Nordisk Foundation, Lundbeck Foundation, and the Danish Heart Foundation. Benedikt Schrage has received lecture honorarium from Abbott, Abiomed, and AstraZeneca as well as research grants from Abiomed, the German Research Foundation, the Else Kröner-Fresenius-Stiftung and the University of Hamburg.